MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$12,411K
Net Income
-$5,618K
Net Profit Margin
-45.27%
EPS
-$0.53
Unit: Thousand (K) dollars
Revenue Breakdown
ADHDPortfolio
EXXUAPortfolio
The Pediatric Portfolio
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenue
12,411
15,165
13,888
13,844*
Cost of goods sold
4,812
5,541
4,702
5,199*
Gross profit
7,599
9,624
9,186
8,645*
Selling and marketing
5,929
5,998
5,322
11,999*
General and administrative
4,973
5,070
4,924
3,528*
Research and development
0
0
0
444*
Amortization of intangible assets
761
526
444
922*
Restructuring costs
0
0
0
-251*
Impairment expense
-
-
-
2,066*
Total operating expenses
11,663
11,594
10,690
18,707*
(loss) income from operations
-4,064
-1,970
-1,504
-10,062*
Other income, net
149
190
201
-1,379*
Interest expense
436
560
516
862*
Derivative warrant liabilities (loss) gain
-1,257
-8,244
3,784
-9,414*
Loss on extinguishment of debt
-
-
-
0*
(loss) income from continuing operations before income tax expense
-5,608
-10,584
1,965
-21,718*
Income tax (expense) benefit
10
0
0
13*
Net (loss) income from continuing operations
-5,618
-10,584
1,965
-21,731*
Net income from discontinued operations, net of tax
0
0
0
-32*
Net (loss) income
-5,618
-10,584
1,965
-21,764
Basic EPS
-0.53
-1.05
0.21
-3.279
Diluted EPS
-0.53
-1.05
-0.08
-
Basic Average Shares
10,511,583
10,036,359
9,441,073
6,636,579
Diluted Average Shares
10,511,583
10,036,359
19,476,635
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
-$5,618K
(-240.66%↓ Y/Y)
Net (loss) income
from continuing...
-$5,618K
(-242.59%↓ Y/Y)
ADHDPortfolio
$9,093K
EXXUAPortfolio
$2,397K
The Pediatric
Portfolio
$921K
(loss) income from
continuing operations...
-$5,608K
(-246.88%↓ Y/Y)
Income tax (expense)
benefit
$10K
(108.20%↑ Y/Y)
Other income, net
$149K
(313.89%↑ Y/Y)
Net revenue
$12,411K
(-32.74%↓ Y/Y)
(loss) income from
operations
-$4,064K
(-267.86%↓ Y/Y)
Derivative warrant
liabilities (loss) gain
-$1,257K
(-155.59%↓ Y/Y)
Interest expense
$436K
(-51.56%↓ Y/Y)
Gross profit
$7,599K
(-40.66%↓ Y/Y)
Cost of goods sold
$4,812K
(-14.77%↓ Y/Y)
Total operating
expenses
$11,663K
(12.31%↑ Y/Y)
Selling and marketing
$5,929K
(14.15%↑ Y/Y)
General and
administrative
$4,973K
(21.03%↑ Y/Y)
Amortization of intangible
assets
$761K
(-17.28%↓ Y/Y)
Buy us a coffee
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)